| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/13/2013 | CN102961347A Oral solid medicinal composition for treating xerosis and preparation method thereof |
| 03/13/2013 | CN102961345A Method for preparing rapamycin/magnetic carboxymethyl chitosan nano drug-loaded microspheres |
| 03/13/2013 | CN102961278A Hypoallergenic toothpaste |
| 03/13/2013 | CN102960183A Artificial culture method for Cordyceps sinensis and Cordyceps sinensis product |
| 03/13/2013 | CN102433248B Selenium-rich sika deer pilos antler health-preserving wine and preparation method thereof |
| 03/13/2013 | CN102344880B Health wine and production method thereof |
| 03/13/2013 | CN102247350B Application of eriocalyxin in preparation of medicaments for treating autoimmune diseases |
| 03/13/2013 | CN102145024B Fungal composition with effect of enhancing immunity and preparation method thereof |
| 03/13/2013 | CN102078394B Aconite extract-containing medicinal composition, preparation method and application thereof |
| 03/13/2013 | CN102018963B MiR-125a for adjusting regulated on activation normal T cell expressed and secreted (RANTES) expressions as well as composition and application thereof |
| 03/13/2013 | CN101980721B Antigendrug excipient comprising synthetic peptide, and mucosal vaccine using the same |
| 03/13/2013 | CN101954095B Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 03/13/2013 | CN101914458B Candida albicans (mannose protein complex) strain |
| 03/13/2013 | CN101869299B Cichorium endivia L. extract and application thereof |
| 03/13/2013 | CN101851278B B cell activating factor antagonist as well as preparation method and application thereof |
| 03/13/2013 | CN101748096B Sub totipotential stem cell and preparation method and application thereof |
| 03/13/2013 | CN101503356B Novel method for preparing high-purity chlorogenic acid |
| 03/13/2013 | CN101058800B Animal protein free media for cultivation of cells |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394817 CCR1 antagonists and methods of use therefor |
| 03/12/2013 | US8394806 2-phenyl pyrazines as tubulin inhibitors |
| 03/12/2013 | US8394369 Chondrocyte therapeutic delivery system |
| 03/12/2013 | US8394368 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/12/2013 | CA2676842C Methods of releasing sporocysts from oocysts using controlled shear forces |
| 03/12/2013 | CA2676185C Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 03/12/2013 | CA2603826C Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 03/12/2013 | CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 03/12/2013 | CA2464111C Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | CA2461714C Treatment of chronic joint inflammation |
| 03/12/2013 | CA2407910C Antibodies that immunospecifically bind to blys |
| 03/12/2013 | CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine |
| 03/12/2013 | CA2285923C Methods and compositions for treating inflammatory bowel disease |
| 03/07/2013 | WO2013033620A1 Compounds and compositions as pdgfr kinase inhibitors |
| 03/07/2013 | WO2013033602A2 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | WO2013033400A2 Methods for effectively and rapidly desensitizing allergic patients |
| 03/07/2013 | WO2013033395A1 MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE |
| 03/07/2013 | WO2013033155A1 Methods and compositions for reducing serum levels of immunoglobulin e (ige) |
| 03/07/2013 | WO2013033104A1 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR DECTIN-1 AND TOLL-LIKE RECEPTOR 2 (TLR2) |
| 03/07/2013 | WO2013032905A1 Modulating wnt activity by targeting gpr177 |
| 03/07/2013 | WO2013032591A1 Heterocyclic compounds and uses thereof |
| 03/07/2013 | WO2013032032A1 Anti-human xcr1 antibodies |
| 03/07/2013 | WO2013031931A1 Chemokine receptor activity regulator |
| 03/07/2013 | WO2013031831A1 Method for improving therapy for autoimmune diseases such as rheumatoid arthritis |
| 03/07/2013 | WO2013030778A2 Organic compositions to treat hsf1-related diseases |
| 03/07/2013 | WO2013030568A1 Caninised tumour necrosis factor antibodies and methods of using the same |
| 03/07/2013 | WO2013030218A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | WO2013029479A1 Mycophenolic acid derivative and preparation method and use thereof |
| 03/07/2013 | WO2013029338A1 Novel compounds |
| 03/07/2013 | WO2013009519A3 Materials for treating and preventing mucosa related disease |
| 03/07/2013 | WO2012177678A3 Isotopologues of pomalidomide |
| 03/07/2013 | WO2012169741A3 Fcεri-specific human antibody and composition comprising same for treating or diagnosing allergic diseases |
| 03/07/2013 | WO2012004273A3 Array of age-tailored nutritional formula with optimum fat content |
| 03/07/2013 | US20130060235 Pharmaceutical compositions and methods of use |
| 03/07/2013 | US20130059901 Pre-MRNA Trans-Splicing Molecule (RTM) Molecules and Their Uses |
| 03/07/2013 | US20130059886 Polymorphic form of fexofenadine hydrochloride, intermediates and process for its preparation |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059878 Treatment of diseases modulated by a h4 receptor agonist |
| 03/07/2013 | US20130059846 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059832 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059821 Bicyclic aryl sphingosine 1-phosphate analogs |
| 03/07/2013 | US20130059816 Compositions and methods for treatment of autoimmune and other disease |
| 03/07/2013 | US20130059801 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | US20130059798 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/07/2013 | US20130059788 Prodomain modulators of adam 10 |
| 03/07/2013 | US20130059752 Compositions and methods for the treatment of immune related diseases |
| 03/07/2013 | US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin |
| 03/07/2013 | US20130059009 Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers |
| 03/07/2013 | US20130058997 Vaccine composition containing synthetic adjuvant |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058984 Single-walled carbon nanotube/bioactive substance complexes and methods related thereto |
| 03/07/2013 | US20130058980 Small molecule inhibitors of protein kinases |
| 03/07/2013 | US20130058978 Induced tolerogenic dendritic cells for inducing regulatory b cells |
| 03/07/2013 | US20130058977 Compositions and methods related to induced tolerogenic dendritic cells externally loaded with mhc class i-restricted epitopes |
| 03/07/2013 | US20130058976 Allergen-specific induced tolerogenic dendritic cells for allergy therapy |
| 03/07/2013 | US20130058975 Antigen-specific induced tolerogenic dendritic cells to reduce antibody responses |
| 03/07/2013 | US20130058974 Antigen-specific induced tolerogenic dendritic cells to reduce cytotoxic t lymphocyte responses |
| 03/07/2013 | US20130058973 Immune therapy |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058970 Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines |
| 03/07/2013 | US20130058967 Recombinant modified bacillus anthracis protective antigen for use in vaccines |
| 03/07/2013 | US20130058966 Anti-pdef antibodies and uses thereof |
| 03/07/2013 | US20130058965 Injectable formulations for parenteral administration |
| 03/07/2013 | US20130058964 Methods for activating t cells and modulating an immune response |
| 03/07/2013 | US20130058963 Induced tolerogenic dendritic cells for generating cd8+ regulatory t cells |
| 03/07/2013 | US20130058961 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| 03/07/2013 | US20130058956 Extracellular ifi16 as therapeutic agents |
| 03/07/2013 | US20130058933 Monovalent ligands of the human cd28 receptor |
| 03/07/2013 | US20130058930 Subcutaneous needle assisted jet injection administration of methotrexate |
| 03/07/2013 | US20130058920 METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE |
| 03/07/2013 | US20130058919 Optimized Fc Variants and Methods for their Generation |
| 03/07/2013 | US20130058917 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/07/2013 | US20130058909 Methods of treatment using ex vivo expansion of cord blood t cells |
| 03/07/2013 | US20130058902 Dendritic cell subsets for generating induced tolerogenic dendritic cells and related compositions and methods |
| 03/07/2013 | US20130058898 Lactic acid bacterium-containing preparation |
| 03/07/2013 | US20130058894 Therapeutic protein-specific induced tolerogenic dendritic cells and methods of use |
| 03/07/2013 | US20130058891 Kexin-Derived Vaccines to Prevent or Treat Fungal Infections |